Abstract
It is not uncommon to find statements in the social media and even in some scientific journals declaring that embryonic stem cells can be used in human medicine for therapeutic purposes. In our opinion, this statement does not fit the medical reality. To go into this subject in depth, and if possible to clarify it, we reviewed the most recent literature on clinical trials conducted with embryonic stem cells, concluding that up to the present time, there is only one ongoing clinical trial being carried out with these types of cells to treat a small group of patients with spinal cord injury. The results of this trial have still not been published. In conclusion, at present, there is only evidence of one phase I clinical trial conducted with embryonic stem cells, in comparison to the numerous trials conducted with adult stem cells.
Similar content being viewed by others
References
Alper J (2009) Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol 27:213–214
Amariglio N, Hirshberg A, Scheithauer BW (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6(2):e1000029
Burt RK, Loh Y, Pearce W et al (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299:925–936
Chidgey AP et al (2008) Tolerance strategies for stem-cell-based therapies. Nature 453:330–337
Enserink M (2006) Selling the stem cell dream. Science 313:160–163
Fox JL (2008) FDA scrutinizes human stem cell therapies. Nat Biotechnol 26:598–599
Geron (2009) Geron receives FDA clearance to begin world’s first human clinical trial of embryonic stem cell-based therapy. http://www.geron.com/media/pressview.aspx?id=1148. Accessed 29 Sept 2009
Hadassah Medical Organization (2009) Derivation of new human embryonic stem cell lines for clinical use. This study is currently recruiting participants. September 2009. www.clinicaltrials.gov. Identifier: NCT 00353210
Hadassah Medical Organization (2009) Derivation of new human embryonic stem cell lines for clinical use. This study is currently recruiting participants. September 2009. www.clinicaltrials.gov. Identifier: NCT 00581152
Herderson M (2009) Stem-cell deal raises hopes of finding cure for blindness. Times. Online 24 April 2009
http://www.stemcellresearch.org/facts/CheckTheScore.pdf Adult stem cells vs. embryonic stem cells. Benefits in human patients (from peer-reviewed studies). Updated11 Apr 2007.
Klimanskaya I, Rosenthal N, Laura R (2008) Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev 7:131–142
Memorial Sloan-Kettering Cancer Center (2009) Molecular characterization of neuroblastic tumor: correlation with clinical outcome. This study is ongoing, but not recruiting participants. July 2009. www.clinicaltrials.gov. Identifier: 00588068
Monash University (2009) Evaluation of circulating levels of adult stem cells in the peripheral blood of patients with acute decompensated heart failure and following stabilization, in comparison with healthy volunteers. This study is ongoing, but not recruiting participants. December 2009. www.clinicaltrials.gov. Identifier. NCT 01027403
National Cancer Institute (2008) Studying breast stem cells from patients with cancer and from healthy individuals. This study is ongoing, but not recruiting participants. August 2008. www.clinicaltrials.gov Identifier: NTC 00900315
National Institutes of Health (2009) Isolation and characterization in mammary stem cells. This study is ongoing, but not recruiting participants. December 2009. www.clinicaltrials.gov. Identifier: NCT 00340392
Prentice D (2004) Adult stem cells. Appendix K in monitoring stem cell research: a report of the President’s Council on Bioethics. GPO, Washington, DC, pp 309–346
Prentice D, Tarne G (2007) Treating diseases with adult stem cells. Science 315:328
Royan Institute. Patient-specific induced pluripotency stem cells (PSiPS). This study is ongoing, but not recruiting participants. August 2009. www.clinicaltrials.gov. Identifier: NCT 00953693
Tabar V et al (2008) Therapeutic cloning in individual parkinsonian mice. Nat Med. doi:10.1038/nm1732
University of California (2007) The role of TBX3 in human ES cell differentiation. This study is ongoing, but not recruiting participants. December 2007. www.clinicaltrials.gov. Identifier: NCT 00581152
University of Miami (2009) The transendocardial autologous cells (hMSC or hBMC) in ischemic heart failure trial (TAC-HFT). This study is ongoing, but not recruiting participants. April 2009. www.clinicaltrials.gov. Identifier: NCT: 007680066
Wadman M (2009) Human embryonic stem cell trial wins approval. Nature News. doi:10.1038/news.2009.56
www.clinicaltrials.gov. A service of the U.S. National Institute of Health. Registry of federally and privately supported clinical trials conducted in the United States and around the world. Accessed 30 October 2010
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aznar, J., Luis Sánchez, J. Embryonic stem cells: are useful in clinic treatments?. J Physiol Biochem 67, 141–144 (2011). https://doi.org/10.1007/s13105-010-0064-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-010-0064-0